A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
PHASE3
The purpose of this study is to assess the efficacy of ruxolitinib against ...
Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies
PHASE2
This phase II trial is studying the side effects and how well giving fludar...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
PHASE2
This study will be conducted to compare Axatilimab Versus Best Available Th...